Clinical trials
Phase 3 trials in North Macedonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
100 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 9 |
| 2008 | 7 |
| 2009 | 6 |
| 2010 | 7 |
| 2011 | 5 |
| 2012 | 7 |
| 2013 | 5 |
| 2014 | 5 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 76 |
| Terminated | 11 |
| Active, not recruiting | 9 |
| Enrolling by invitation | 2 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 24 |
| Hoffmann-La Roche | 16 |
| Janssen Research & Development, LLC | 4 |
| Teva Branded Pharmaceutical Products R&D, Inc. | 4 |
| Biogen | 3 |
| Sanofi | 3 |
| Tanabe Pharma Corporation | 3 |
| Areteia Therapeutics | 2 |
| Astria Therapeutics, Inc. | 2 |
| BioCryst Pharmaceuticals | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 15 |
| Diabetes Mellitus, Type 1 | 10 |
| Diabetes Mellitus, Type 2 | 10 |
| Angioedemas, Hereditary | 8 |
| Multiple Sclerosis | 8 |
| Breast Neoplasms | 7 |
| Renal Insufficiency, Chronic | 6 |
| Hemophilia A | 5 |
| Multiple Sclerosis, Relapsing-Remitting | 4 |
| Pulmonary Disease, Chronic Obstructive | 4 |
Trials
Showing 1 to 25 of 100. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.